Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Beneficial effects reported for FR-167653 in rat model of myocarditis

Nov. 4, 1999

News from ET-6: selective endothelin ETA antagonists from Knoll/BASF

Nov. 3, 1999

MCC-135 restores impaired Ca2+-ATPase activity in the postischemic myocardium

Nov. 3, 1999

Rock/Rho kinase inhibitor Y-27632: a promising vasodilator for treatment of heart failure

Nov. 3, 1999

New therapeutic agents for heart failure: heart rate-lowering chromanes

Nov. 3, 1999

Harvard team succeeds in promoting angiogenesis in coronary arteries

Nov. 2, 1999

CGS-35066: potent and specific ECE inhibitor presented at ET-6

Nov. 2, 1999

New type III antiarrhythmic marketed in Japan

Nov. 2, 1999

AGI-1067 and related AtheroGenics compounds licensed to Schering-Plough

Oct. 29, 1999

ETA/ETB antagonist tezosentan is a promising parenteral treatment for acute conditions

Oct. 29, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...